Working Document, September 2017
Scientific advice
Prevention and control of communicable diseases in prison settings.
Practical Guidance for collaborative interventions
WHO working group on HIV incidence assays meeting report
10–11 December 2015
Glion, Switzerland
UNAIDS/WHO working group on global HIV/AIDS and STI surveillance
WHO/HIV/2017.03
Each unit builds on the one prior, and they all combine to provide key information for developing an SBCC strategy. It is not essential, however, to work through the I-Kit from start to finish. Users can choose to focus on specific aspects for which they need support in their emergency communication... response. The nine units and corresponding worksheets are outlined in the I-Kit Site Navigator.
more
Topics in Antiviral Medicine Volume 25 Issue 2 May/June 2017
Technical Update
HIV Treatment
July 2017
Lessons from the STEP-TB Project.
Accessed November 2017.
Information note
Accessed November 2017.
A review of available evidence (2016).
28-29 June 2016; Geneva, Switzerland
The END TB strategy.
This I-Kit provides essential information and tools for responding to an outbreak using an SBCC approach. It presents a series of nine units, each accompanied by exercise worksheets to help link the SBCC theory to practice.
The worksheets in each section are typically followed by a completed exam...ple. The completed examples will likely include information about an emergency that, during an actual event, might not be immediately available. This was done to illustrate the full range of information to inform a strategic communication response.
more
Guidelines for treatment of drug-susceptible tuberculosis and patient care
Update 2017
National Tuberculosis and Leprosy Conrol Programme
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an...d over 15 million people with lymphoedema. At least 36 million persons remain with these chronic disease manifestations. The disease is endemic in 72 countries. In 2016, an estimated total population of 856 million were living in areas with ongoing transmission of the causative filarial parasites and requiring mass drug administration (MDA). Lymphatic filariasis disfigures and disables, and often leads to stigmatization and poverty. Hundreds of millions of dollars are lost annually due to reduced productivity of affected patients. WHO has ranked the disease as one of the world’s leading causes of permanent and long-term disability.
more